InvivoChem Cat #:V1925CAS #:1428333-96-3 Purity >=98%Description: Pritelivir mesylate (formerly known as AIC316 mesylate, BAY 57-1293 mesylate) is a novel and potent helicase primase inhibitor that showed antiviral effect on herpes simplex virus (HSV) with IC50 of 20 nM for both HSV-1 and HSV-2. It represents a new class of potent inhibitors of HSV that target the virus helicase primase complex. BAY 57-1293 exhibits anti-herpes activity through inhibiting the helicase-primase and affecting the viral DNA synthesis. In the in vitro viral replication assay, BAY 57-1293 shows inhibition against HSV-1 F, HSV-2 G and acyclovir-resistant HSV-1 F mutant with IC50 value of 20nM. Thus, BAY 57-1293 has significant potential for the treatment of HSV disease in humans, including those resistant to current medications.
References: Nat Med. 2002 Apr; 8(4):392-8; Antimicrob Agents Chemother. 2002 Jun; 46(6):1766-72.
Related CAS#:1428333-96-3 (mseylate); 348086-71-5 (free base); 910864-57-2 (HCl); 910864-61-8 (besylate); 2088209-68-9 (sulfate)
Related CAS#:1428333-96-3 (mseylate); 348086-71-5 (free base); 910864-57-2 (HCl); 910864-61-8 (besylate); 2088209-68-9 (sulfate)